Skip to content
SEC filings edition: Friday, November 13, 2026 · 767 companies with filings Publisher's serviceBoardeon, your AI board · Hire your board →
Monday, November 16, 2026Every business day from SEC EDGAR
SEC EDGAR · Nov 13, 2026 1bankruptcies 11delisting notices 12late filings 43leadership changes 6IPO filings 199private raises 90earnings releases
Company page · CIK 1835579 · IMA

ImageneBio, Inc.

Filing with the SEC SEC-reporting company San Diego, CA Nasdaq
An email when it files something new with the SEC. Your account

What this means

  • Several leadership changes3 reports of director or officer changes (Item 5.02) in the last 180 days.
  • Net loss in 2025Net loss of $45.3M for the year (2024: −$36.6M).
  • Revenue downRevenue fell from $3.5M in 2024 to $800K in 2025 (77% lower).

What to do next

Guides from the Companies Daily newsroom, picked for what the register shows.

Financials from XBRL

Calendar-year frame20252024
Revenue$800K$3.5M
Net income (loss)−$45.3M−$36.6M
Total assets$153M$15.9M
Total liabilities$19.8M$17.4M
Stockholders’ equity$133M−$161M
Cash and equivalents$94.5M$12.1M

From XBRL data the company filed with the SEC (data.sec.gov frames, US GAAP, US dollars). A frame aligns the fiscal year with the calendar year closest to it; this company’s fiscal year ends December 31. Check the annual report for the exact figures and periods.

Name as filed
ImageneBio, Inc.
Formerly: Ikena Oncology, Inc.
CIK
0001835579
Tickers
IMA
Kind of filer
SEC-reporting company
Emerging growth company
Status
Filing with the SEC
State of incorporation
Delaware
Business address
San Diego, California
Industry (SIC)
2836 · Biological products, (no diagnostic substances)
Industry: D · Manufacturing →
Fiscal year ends
December 31
Last annual report
10-K for the period ended Dec 31, 2025
Last quarterly report
10-Q for the quarter ended Sep 30, 2026
Bankruptcy reported
Not in our data
Last edition event
Nov 9, 2026

Filing history

Newest first: the filings we classify (8-K items, late filing notices, delistings, deregistration, IPO registrations, Schedule 13D, Form D, annual and quarterly reports), from Jan 1, 2023. All documents, including those we do not classify, are in the EDGAR filing index.

  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2026
    Form 10-Q · filed Nov 9, 2026 · filing · edition of Nov 9, 2026
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Nov 9, 2026 · filing · edition of Nov 9, 2026
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Aug 5, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2026
    Form 10-Q · filed Aug 5, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 8.01, 9.01 · filed Jul 23, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Jun 26, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 5.07, 9.01 · filed Jun 17, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed May 7, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2026
    Form 10-Q · filed May 7, 2026 · filing
  • Stake of 5% or more with intent to influence: Schedule 13D: stake of 5% or more
    Form SCHEDULE 13D · filed Apr 21, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Mar 17, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Mar 10, 2026 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2025
    Form 10-K · filed Mar 10, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Feb 17, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Dec 18, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Nov 12, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2025
    Form 10-Q · filed Nov 12, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Nov 5, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Oct 22, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Oct 10, 2025 · filing
  • IPO registration filed: Registration statement (S-1)
    Form S-1 · filed Sep 8, 2025 · filing
  • Change of auditor
    Form 8-K · items 4.01, 9.01 · filed Aug 5, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 8.01, 9.01 · filed Aug 1, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 1.01, 2.01, 3.02, 3.03, 5.01, 5.02, 5.03, 5.06, 7.01, 9.01 · filed Jul 29, 2025 · filing
  • Change in control
    Form 8-K · items 1.01, 2.01, 3.02, 3.03, 5.01, 5.02, 5.03, 5.06, 7.01, 9.01 · filed Jul 29, 2025 · filing
  • Acquisition or disposal completed
    Form 8-K · items 1.01, 2.01, 3.02, 3.03, 5.01, 5.02, 5.03, 5.06, 7.01, 9.01 · filed Jul 29, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2025
    Form 10-Q · filed Jul 24, 2025 · filing
  • Private raise (Form D)
    Form D · items 06b · filed Jul 18, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Jul 16, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 5.07, 8.01, 9.01 · filed Jul 15, 2025 · filing
  • Stake of 5% or more with intent to influence: Schedule 13D: stake of 5% or more
    Form SCHEDULE 13D · filed Jun 16, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2025
    Form 10-Q · filed May 8, 2025 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2024
    Form 10-K · filed Mar 6, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 1.01, 3.02, 5.01, 5.02, 7.01, 9.01 · filed Dec 23, 2024 · filing
  • Change in control
    Form 8-K · items 1.01, 3.02, 5.01, 5.02, 7.01, 9.01 · filed Dec 23, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2024
    Form 10-Q · filed Nov 7, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2024
    Form 10-Q · filed Aug 8, 2024 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Jul 12, 2024 · filing
  • Restructuring or layoffs
    Form 8-K · items 2.05, 7.01, 8.01, 9.01 · filed May 28, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2024
    Form 10-Q · filed May 13, 2024 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2023
    Form 10-K · filed Mar 12, 2024 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 7.01, 9.01 · filed Feb 21, 2024 · filing
  • Restructuring or layoffs
    Form 8-K · items 2.02, 2.05, 7.01, 8.01, 9.01 · filed Jan 18, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 2.05, 7.01, 8.01, 9.01 · filed Jan 18, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 8.01, 9.01 · filed Nov 9, 2023 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2023
    Form 10-Q · filed Nov 9, 2023 · filing
  • Private raise (Form D)
    Form D · items 06b · filed Aug 18, 2023 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2023
    Form 10-Q · filed Aug 10, 2023 · filing
  • Acquisition or disposal completed
    Form 8-K · items 1.01, 2.01, 3.02, 5.03, 7.01, 9.01 · filed Aug 7, 2023 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed Jun 30, 2023 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2023
    Form 10-Q · filed May 15, 2023 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2022
    Form 10-K · filed Mar 14, 2023 · filing